The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...
The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...
New direct admission program offers eligible students a streamlined pathway to higher education
RALEIGH, N.C., Aug. 6, 2025 /PRNewswire/ -- Starting this fall, more than 62,000 North...
The Biomarkers Market is anticipated to expand at a rapid pace due to the increasing demand for personalized medicine, rising prevalence of chronic and...
Fifth-Year Cohort of Scholars Selected from Nearly 400 Applicants Across 20 DPT Programs Nationwide
PHOENIX, Aug. 6, 2025 /PRNewswire/ -- Rizing Tide, a foundation dedicated to...
NEW YORK and NEW ORLEANS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 26, 2025 to file lead plaintiff applications in a securities class action lawsuit against Sable Offshore Corp. (NYSE: SOC), if they purchased the Company’s securities (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to Sable’s May 21, 2025 secondary public offering (the “SPO”). This action is pending in the United States District Court for the Central District of California.
The vitiligo market is witnessing steady growth due to rising disease awareness, improved diagnostic capabilities, and advancements in treatment options such as JAK inhibitors...
Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).
NEWARK, N.J., Aug. 5, 2025 /PRNewswire/ -- New Jersey Innovation Institute (NJII), a subsidiary of the New Jersey Institute of Technology (NJIT), is pleased...
The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to...
The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to...